Société Auris Medical Holding Ltd. Börse Stuttgart
Actions
2QAA
BMG070252017
Recherche biotechnologique et médicale
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Thomas Meyer
CEO | Chief Executive Officer | 56 | 01/04/03 |
Marcel Gremaud
DFI | Director of Finance/CFO | 66 | 01/11/21 |
Covadonga Pañeda
COO | Chief Operating Officer | 51 | - |
Samuel Wickline
CTO | Chief Tech/Sci/R&D Officer | 71 | 01/06/21 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Alain Munoz
BRD | Director/Board Member | 75 | 01/03/18 |
Mats Blom
BRD | Director/Board Member | 59 | 01/04/17 |
Thomas Meyer
CEO | Chief Executive Officer | 56 | 01/04/03 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 2 240 245 | 2 220 245 ( 99,11 %) | 0 | 99,11 % |
Coordonnées société
Altamira Therapeutics Ltd.
Clarendon House 2 Church Street
HM 11, Hamilton
+441 295 5950
http://www.altamiratherapeutics.com![Adresse Auris Medical Holding Ltd.(2QAA)](https://cdn.zonebourse.com/static/address/57948178.png)
Secteur
Varia. 1 janv. | Capi. | |
---|---|---|
+15,19% | 121 Md | |
+19,91% | 114 Md | |
+8,24% | 23,61 Md | |
-19,80% | 20,43 Md | |
-16,19% | 16,55 Md | |
-13,45% | 16,45 Md | |
-44,35% | 15,59 Md | |
+2,13% | 13,54 Md | |
+66,67% | 15,19 Md |